Archive for January, 2011

CRMD takes wing, NVDA dizzy, RFMI turfs

Wednesday, January 12th, 2011

CorMedix Inc. (AMEX: CRMD) shares gained 20.5% to $2.14 Wednesday. Volume of 157,948 proved nine times its full-day average. CRMD is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac and renal dysfunction.

NVIDIA Corporation (Nasdaq: NVDA) traded in 57,205,492 shares Wednesday, nearly tripling its daily average. Prices for NVDA leapt 12.5 percent to $22.85. The chip maker’s stock is now up more than 100% over the past three months amid upbeat analyst reviews of its recent initiatives, particularly in the tablet and smart phone markets.

RF Monolithics, Inc. (Nasdaq: RFMI) fell 5.7 percent Wednesday to $1.82 Volume for the stock was 252,129 shares or more than eight times its daily average. Tuesday, the Dallas-based RFMI reported quarterly net income of $160,000 or $0.01 per share.

INHC a leader, GERS trades, BNGOF plummets

Wednesday, January 12th, 2011

Innolog Holdings Corp (OTCBB: INHC) rocketed up 166.7 percent Wednesday to eight cents, on volume of 49,490 shares. This compares to 16,578 on an average day. INHC is a holding company for the purpose of acquiring businesses that provide services primarily to federal government entities.

Greenshift Corp. (OTCBB: GERS) was active Wednesday, trading in 56 million shares, catching up on its all-day average of 66 million. Prices for GERS were flat at two-100ths of a cent. GERS develops and commercializes clean technologies.

Bingo.com Ltd. (OTCBB: BNGOF) plummeted in price by 53.8 percent to six cents Wednesday. Volume for the stock was 27,140 shares, short of its daily average of 44,552. BNGOF is the parent company of the Bingo.com group of companies.

CRIS incredible, MU moves shares, THOR loses ground

Wednesday, January 12th, 2011

Curis Inc. (Nasdaq: CRIS) shares gained 20.2% to $2.74 Wednesday. Volume of 1,361,514 proved four times its full-day average. The Mass.-based CRIS is a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment.

Micron Technology Inc. (Nasdaq: MU) traded in 53,997,533 shares Wednesday, nearly doubling its daily average of 30,541,700. Prices for MU were up 7.1 to $9.34.

Thoratec Corporatino (Nasdaq: THOR) fell 7.4 percent Wednesday to $28.81. Volume for the stock was 4,263,232 shares or three times its daily average. THOR is a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts.

ITT is it, GE active, CPF falters

Wednesday, January 12th, 2011

ITT Corp. (NYSE: ITT) shares gained 13.9% to $60.10 Wednesday after the defense contractor said it would split into three separate publicly traded companies. Volume of 14,510,255 overwhelmed a full-day average of 1,262,170.

General Electric Company (NYSE: GE) traded in 31,018,867 shares Wednesday, just better than half its all-day average of 57,041,400. Prices for GE were flat at $18.64. Wednesday, GE Intelligent Platforms announced the PCIE-5565PIORC low profile PCI Express reflective memory node card

Central Pacific Financial Corp. (NYSE: CPF) fell 8.2 percent Wednesday to $2.25. Volume for the stock was 924,167 shares or nearly 4 1/2 times its daily average, only a day after double-digit stock gains.

SDIX soars, BAC busy, KV troubled

Wednesday, January 12th, 2011

Strategic Diagnostics Inc. (Nasdaq: SDIX) shares shot higher 42.5 percent Wednesday to $2.65, on volume of 2,094,668 shares, towering over its full-day average of about 31,000. SDIX announced Wednesday its RapidChek SELECT Salmonella Enteritidis (SE) test system has been reviewed by FDA and determined to be equivalent in accuracy, precision and sensitivity to their current standard methods for poultry house environmental drag swabs and pooled egg testing.

Bank of America Corp. (NYSE: BAC) traded in 113,699,846 shares noon Wednesday, nearly half its all-day average. Prices for BAC moved forward 1.8 percent to $14.95, as part of a general upward trend for bank stocks.

K-V Pharmaceutical Company (NYSE: KV.A) fell 21.9 percent Wednesday to $1.78. Volume for the stock was 1,722,746 shares or nearly five times its daily verage, after the company said it was “evaluating its liquidity outlook” in light of a delay by U.S. regulators over approval of a treatment to prevent preterm birth.